The hemodynamic effects of dopamine were studied in 62 patients with clinical shock. In 36 patients with infection dopamine increased mean arterial pressure (MAP) 30%, and cardiac output (CO) 37%. Urine flow (UF) increased from 0.5 ml/min to 1.6 ml/min. Norepinephrine (NE) 
Because hemodynamic changes unrelated to therapy occur during shock, the study was designed to assess just the acute hemodynamic responses to each agent so that all three drugs could be evaluated within a 2-to 3-hr period. Each drug was infused at a constant rate for 30 min or until a new steady state was obtained. Hemodynamic measurements were made and the drug was discontinued. After a 30-min control period hemodynamic studies were repeated and the next drug infusion started. In a few patients it was not possible to achieve a steady state for the control period between drug infusions. The order in which the drugs were infused was randomized whenever possible. The infusion rates for each drug were adjusted to raise the mean arterial pressure (MAP) to between 70 and 90 mm Hg, or to increase MAP by 20 mm Hg in patients whose control pressures were not reduced. When a pressor response did not occur, the drugs were infused in amounts known from past experience to exert significant hemodynamic effects. Dopamine was infused in amounts of from 0.1 to 1.6 mg per min (average 0.75 mg per min).
Studies were performed in a specially equipped We compared dopamine and NE in 26 patients with shock due to infection. Although NE resulted in a significantly higher mean arterial pressure (MAP) than did dopamine, it was possible to maintain MAP at adequate levels with dopamine in all but a few patients.
CO was significantly higher with dopamine than with NE and LVEDP was significantly lower. However, mean values for UF were LOEB ET AL. similar with both agents. Our data thus do not clearly show superiority of either dopamine or NE in these patients. Because dopamine infusion results in higher CO 
